当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Cell Death and Differentiation杂志
Cell Death and Differentiation
基本信息
期刊名称 Cell Death and Differentiation
CELL DEATH DIFFER
期刊ISSN 1350-9047
期刊官方网站 https://www.nature.com/cdd
是否OA No
出版商 Nature Publishing Group
出版周期 Monthly
文章处理费 登录后查看
始发年份 1997
年文章数 139
影响因子 13.7(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
生物1区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学2区
CELL BIOLOGY 细胞生物学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 24.7 4.102 2.144
Biochemistry, Genetics and Molecular Biology
Molecular Biology
11/410 97%
Biochemistry, Genetics and Molecular Biology
Cell Biology
13/285 95%
补充信息
自引率 1.5%
H-index 193
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1350-9047%5BISSN%5D
投稿指南
期刊投稿网址 https://mts-cdd.nature.com/
收稿范围
To devote itself to scientific excellence in the field of cell biology, molecular biology, and biochemistry of cell death and disease.
    To provide a unified forum for scientists and clinical researchers
    It is committed to the rapid publication of high quality original papers relating to these subjects, together with topical, usually solicited, reviews, meeting reports, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.
收录体裁
Article
Review Article
Perspective
Editorial
Comment
Meeting Report
投稿指南 https://www.nature.com/cdd/authors-and-referees
投稿模板
参考文献格式 https://endnote.com/downloads/styles/
编辑信息

Editors-in-Chief

Gerry Melino 

Gerry Melino, MD (Rome), PhD (London), Dr Sci hc (St Petersburg), working at the MRC Toxicology Unit (Leicester UK) and at the University Tor Vergata of Rome (Italy), has created the major forum for discussion and innovation in the field of cell death in the last twenty years. In fact, his editorial contribution to the scientific community has been pivotal, being the Founder & Editor-in-Chief of the journals Cell Death Differentiation (8.339), Cell Death Disease (5.965), and Cell Death Discovery. His scientific interest focuses upon programmed cell death in epidermal and cancer models, and in particular on the p53 family - p63 and p73, where his contribution has been fundamental.

 Eric H Baehrecke

Eric Baehrecke obtained his Ph.D. from the University of Wisconsin – Madison, and was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation at the University of Utah during his postdoctoral studies. He was a faculty member of the University of Maryland from 1995-2007, and is currently a Professor in the Department of Molecular, Cell and Cancer Biology at the University of Massachusetts Medical School. His team studies the regulation and function of autophagy in cell survival and cell death, and the mechanisms controlling non-apoptotic cell death.

Deputy Editors

Guido Kroemer

Guido Kroemer currently serves as a Research Director at INSERM, in the INSERM Unit 848, located in Villejuif, France. Prior to joining the INSERM (1993), he was Senior Scientist of the European Community at the Spanish National Research Council (CSIC) at the National Center of Molecular Biology (1990-1992) and at the National Center of Biotechnology (1993). He did his postdoctoral training in the Collège de France, Nogent-sur-Marne, France (1988-1989) and at the University of Innsbruck, Austria, after receiving his PhD and MD degrees at the same University in 1985. He also holds a PhD degree in biology (Autonomous University of Madrid, Spain). G. Kroemer is member of EMBO, German Academy of Sciences (Leopoldina), Academia Europaea and European Academy of Sciences and Arts. He received the 2006 Descartes Prize, the highest scientific distinction of the European Union, for his fundamental discoveries in the field of programmed cell death (apoptosis). He also received one of the Grands Prix from the French Academy of Sciences in 2007, as well as the Carus Medal from the German Academy of Sciences. His interests embrace the role of mitochondria in pathological cell death, the contribution of autophagy to disease processes, and the immune response to dying cancer cells.

Richard A Knight

Honorary Senior Lecturer in the Medical Molecular Biology Unit, Institute of Child Health, University College London, and member of the Apoptosis and Cancer Laboratory, Medical Research Council Toxicology Unit, Leicester, UK. Scientific interests include all aspects of cell death, especially in relation to the p53 family, the role of STAT transcription factors in cell cycle control and apoptosis and the mechanisms of cytoprotection by the urocortins, particularly in cardiovascular and neuronal pathologies.
 

Tak W Mak

Tak W. Mak is the Director of the Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, and a University Professor in the Departments of Medical Biophysics and Immunology at the University of Toronto. Dr. Mak received his B.Sc. and M.Sc. degrees from the University of Wisconsin (Madison) and his Ph.D. degree from the University of Alberta. His postdoctoral work was performed at the Ontario Cancer Institute under the supervision of Dr. Ernest McCulloch. Dr. Mak's research interests center on immune cell recognition/regulation, molecular mechanisms underlying the survival and death of normal or malignant cells, as well as the role of inflammation in the progression of autoimmune disease and cancer. He is best known as the lead scientist of the group that first cloned the genes of the human T cell antigen receptor, a discovery that provided essential insights into the molecular basis of cellular immunity. In addition, Dr. Mak has devoted a large portion of his research to investigating the pathogenesis of cancer. In particular, he is interested in mechanisms of metabolic transformation in order to identify potential targets for novel cancer therapeutics.
Dr. Mak has published over 800 peer-reviewed research papers and holds many patents. His many accomplishments have been recognized by the scientific community through numerous prestigious awards and honours, such as the, Emil von Behring Prize, Gairdner International Award, King Faisal International Prize for Medicine, Sloan Prize, and Novartis Immunology Prize. He is a Fellow of the Royal Society of London, a Foreign Associate of the National Academy of Sciences (USA), an Officer of the Orders of Ontario and Canada and a Fellow of American Association for Cancer Research Academy (USA).

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug